Maximizing Tendering Outcomes through Successful Value-based Tendering

This document is a guide that outlines the concept of Value-based Tendering (VBT) in the life sciences industry, emphasizing its transformative approach to procurement. VBT shifts the focus from traditional price-based tendering to a broader evaluation of value delivered to stakeholders, including patients and healthcare providers. The guide details how VBT is gaining traction in the pharmaceutical sector, where tenders account for a significant portion of the market. It discusses the European Public Procurement Directive and the Most Economically Advantageous Tender (MEAT) framework, which integrates cost and qualitative criteria for a more nuanced evaluation. The document highlights the advantages of VBT, such as enhanced patient outcomes and sustainability gains, while also addressing challenges like quantifying value and regional variations in implementation. It concludes with a systematic approach for organizations to implement VBT effectively, ensuring a competitive advantage in a changing procurement landscape.